Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$351M |
| 2 |
Apple
AAPL
|
+$320M |
| 3 |
Chevron
CVX
|
+$295M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$240M |
| 5 |
ExxonMobil
XOM
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.21B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$417M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$404M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.88% |
| 2 | Financials | 5.4% |
| 3 | Healthcare | 5.17% |
| 4 | Communication Services | 4.22% |
| 5 | Consumer Discretionary | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4926
First Financial Corp
THFF
$958M
| $156K | ﹤0.01% |
3,709
+3,301
| +809% | +$140K |
|
|
IMGN
4927
CALL
DELISTED
Immunogen Inc
IMGN
| $156K | ﹤0.01% |
+57,500
| New | +$249K |
|
4928
Assembly Biosciences
ASMB
$498M
| $155K | ﹤0.01% |
654
+23
| +4% | +$5.82K |
|
4929
Barrett Business Services
BBSI
$959M
| $155K | ﹤0.01% |
8,032
+7,212
| +880% | +$125K |
|
4930
PUT
Cullen/Frost Bankers
CFR
$10.3B
| $155K | ﹤0.01% |
1,600
+1,300
| +433% | +$129K |
|
4931
Direxion Daily Regional Banks Bull 3X ETF
DPST
$458M
| $155K | ﹤0.01% |
+195
| New | +$180K |
|
4932
Liquidity Services
LQDT
$1.22B
| $155K | ﹤0.01% |
20,180
+9,247
| +85% | +$69.2K |
|
|
AD
4933
Array Digital Infrastructure
AD
$3.01B
| $155K | ﹤0.01% |
3,392
-53,344
| -94% | -$2.79M |
|
|
AGFS
4934
DELISTED
AgroFresh Solutions Inc
AGFS
| $155K | ﹤0.01% |
46,306
+9,186
| +25% | +$36.4K |
|
|
STML
4935
DELISTED
Stemline Therapeutics, Inc.
STML
| $155K | ﹤0.01% |
12,080
-28,013
| -70% | -$317K |
|
4936
Independent Bank Corp
IBCP
$787M
| $154K | ﹤0.01% |
7,156
+6,840
| +2,165% | +$154K |
|
4937
PUT
New York Times
NYT
$12.1B
| $154K | ﹤0.01% |
+4,700
| New | +$139K |
|
4938
Ryder
R
$9.83B
| $154K | ﹤0.01% |
2,483
-8,443
| -77% | -$494K |
|
4939
CALL
Sturm, Ruger & Co
RGR
$594M
| $154K | ﹤0.01% |
2,900
-3,000
| -51% | -$164K |
|
4940
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
| $154K | ﹤0.01% |
+6,128
| New | +$153K |
|
|
KBAL
4941
DELISTED
Kimball International
KBAL
| $154K | ﹤0.01% |
+10,888
| New | +$163K |
|
|
SRNE
4942
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $154K | ﹤0.01% |
32,431
-71,241
| -69% | -$187K |
|
4943
Dime Commercial Bancshares
DCOM
$1.8B
| $153K | ﹤0.01% |
5,253
+4,672
| +804% | +$142K |
|
4944
FS KKR Capital
FSK
$2.96B
| $153K | ﹤0.01% |
6,323
-14,551
| -70% | -$361K |
|
4945
Dr. Reddy's Laboratories
RDY
$9.87B
| $153K | ﹤0.01% |
18,920
+3,815
| +25% | +$29K |
|
4946
Astrana Health
ASTH
$1.76B
| $153K | ﹤0.01% |
8,326
+7,601
| +1,048% | +$146K |
|
|
ATNX
4947
DELISTED
Athenex, Inc. Common Stock
ATNX
| $153K | ﹤0.01% |
+626
| New | +$153K |
|
|
CRZO
4948
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $153K | ﹤0.01% |
12,300
-35,600
| -74% | -$423K |
|
|
CRR
4949
DELISTED
Carbo Ceramics Inc.
CRR
| $153K | ﹤0.01% |
43,434
+12,216
| +39% | +$51.2K |
|
4950
NRC Health Common Stock
NRC
$432M
| $152K | ﹤0.01% |
3,944
+3,809
| +2,821% | +$149K |
|
Similar funds
Barclays's Q1 2019 Portfolio in Review
As of Q1 2019, Barclays held 7,695 positions worth $145B, up 12% from $129B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays's Q1 2019 filing shows 645 new, 3,437 increased, 2,565 reduced and 541 closed positions. Its largest new stake was Fox Class B: 2,293,111 shares worth $82.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.53B.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 6.9% a quarter earlier, followed by Financials and Healthcare.
- Barclays's largest Q1 2019 buy was Fox Class B: 2,293,111 shares worth $82.3M.
- Barclays added most to State Street Communication Services Select Sector SPDR ETF in Q1 2019, an estimated $351M increase.
- Barclays's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.53B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2019, selling an estimated $1.21B.
- Barclays's ten largest holdings make up 30% of its $145B portfolio in Q1 2019.
- Barclays opened 645 new positions and closed 541 in Q1 2019.
- Barclays's portfolio value rose 12% quarter-over-quarter to $145B.
Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.